Javascript must be enabled to continue!
P-505 Autologous platelet-rich plasma (PRP) intrauterine application during the assisted reproduction technique
View through CrossRef
Abstract
Study question
Does the use of PRP infused into the endometrium of women undergoing IVF promote endometrial receptivity and embryo implantation?
Summary answer
The promotion of cell proliferation and other growth factors aids in endometrial receptivity, facilitating embryo implantation and contributing to a positive pregnancy outcome.
What is known already
The endometrium is a dynamic tissue capable of growth and differentiation in response to hormonal regulation. Through cell proliferation and growth factors, the tissue attains a functional state that allows for receptivity and embryo implantation.
Study design, size, duration
A prospective study was conducted with 890 participants divided into two groups: 519 control patients (C) and 371 volunteers for PRP application (PRP). The study was approved by the Ethics Committee (58399022.4.0000.5505) and conducted over four years. After signing the informed consent and meeting the inclusion and exclusion criteria, participants had their blood drawn, which was centrifuged in two steps to produce autologous PRP.
Participants/materials, setting, methods
All participants underwent controlled ovarian stimulation, and only PRP group received the prepared PRP via uterine infusion. The retrieved oocytes were injected using the ICSI technique, to both groups. The blastocysts were transferred to the uterus. Follicle, oocyte, fertilization, embryonic development, and pregnancy rates were compared between the groups. For statistical analysis, with age as a control variable, the logistic and linear regression was applied for continuous variables, with α = 5%.
Main results and the role of chance
According to the exclusion criteria, 487 women remained in the C group, and 361 in the PRP group; however, only 10% of them progressed to embryo transfer. Although the number of blastocysts (4.65 vs. 3.27, p = 0.024), Grade A D3 embryos (2.34 vs. 1.97, p = 0.019), blastocyst rate (0.13 vs. 0.05, p < 0.001), and the number of transferred embryos (2.54 vs. 2.34, p < 0.001) were higher in the group of women who received PRP, the number of live births was lower (0.28 vs. 2.00, p = 0.024).
Limitations, reasons for caution
The limitations include the small percentage of participants progressing to embryo transfer. Additionally, confounding factors beyond age might affect results, and long-term effects were not evaluated. Further research with larger sample sizes with placebo group and standardized methods is needed to confirm PRP’s efficacy and safety.
Wider implications of the findings
Autologous PRP suggests potential benefits in improving embryo quality and endometrial receptivity, which could enhance IVF protocols. However, the lower live birth rate indicates the need for caution. The study highlights the importance of standardizing PRP preparation, understanding long-term safety, and conducting further research.
Trial registration number
No
Title: P-505 Autologous platelet-rich plasma (PRP) intrauterine application during the assisted reproduction technique
Description:
Abstract
Study question
Does the use of PRP infused into the endometrium of women undergoing IVF promote endometrial receptivity and embryo implantation?
Summary answer
The promotion of cell proliferation and other growth factors aids in endometrial receptivity, facilitating embryo implantation and contributing to a positive pregnancy outcome.
What is known already
The endometrium is a dynamic tissue capable of growth and differentiation in response to hormonal regulation.
Through cell proliferation and growth factors, the tissue attains a functional state that allows for receptivity and embryo implantation.
Study design, size, duration
A prospective study was conducted with 890 participants divided into two groups: 519 control patients (C) and 371 volunteers for PRP application (PRP).
The study was approved by the Ethics Committee (58399022.
4.
0000.
5505) and conducted over four years.
After signing the informed consent and meeting the inclusion and exclusion criteria, participants had their blood drawn, which was centrifuged in two steps to produce autologous PRP.
Participants/materials, setting, methods
All participants underwent controlled ovarian stimulation, and only PRP group received the prepared PRP via uterine infusion.
The retrieved oocytes were injected using the ICSI technique, to both groups.
The blastocysts were transferred to the uterus.
Follicle, oocyte, fertilization, embryonic development, and pregnancy rates were compared between the groups.
For statistical analysis, with age as a control variable, the logistic and linear regression was applied for continuous variables, with α = 5%.
Main results and the role of chance
According to the exclusion criteria, 487 women remained in the C group, and 361 in the PRP group; however, only 10% of them progressed to embryo transfer.
Although the number of blastocysts (4.
65 vs.
3.
27, p = 0.
024), Grade A D3 embryos (2.
34 vs.
1.
97, p = 0.
019), blastocyst rate (0.
13 vs.
0.
05, p < 0.
001), and the number of transferred embryos (2.
54 vs.
2.
34, p < 0.
001) were higher in the group of women who received PRP, the number of live births was lower (0.
28 vs.
2.
00, p = 0.
024).
Limitations, reasons for caution
The limitations include the small percentage of participants progressing to embryo transfer.
Additionally, confounding factors beyond age might affect results, and long-term effects were not evaluated.
Further research with larger sample sizes with placebo group and standardized methods is needed to confirm PRP’s efficacy and safety.
Wider implications of the findings
Autologous PRP suggests potential benefits in improving embryo quality and endometrial receptivity, which could enhance IVF protocols.
However, the lower live birth rate indicates the need for caution.
The study highlights the importance of standardizing PRP preparation, understanding long-term safety, and conducting further research.
Trial registration number
No.
Related Results
P-387 Autologous Platelet-Rich Plasma (PRP) intrauterine infusion before embryo transfer could improve the treatment outcomes, especially for transferring euploid blastocysts, in recurrent implantation failure patients
P-387 Autologous Platelet-Rich Plasma (PRP) intrauterine infusion before embryo transfer could improve the treatment outcomes, especially for transferring euploid blastocysts, in recurrent implantation failure patients
Abstract
Study question
Is the intrauterine infusion of autologous PRP prior to embryo transfer, especially euploid blastocyst t...
Cytology and histology characteristics of platelet-rich fibrin
Cytology and histology characteristics of platelet-rich fibrin
Background: Platelet-rich fibrin (PRF) is a biomaterial whose frame is a network of fibrin fibers containing cells from peripheral blood and growth factors. PRF biomaterials have g...
Protocol for PRP Therapy with Physiotherapy for Shoulder Adhesive Capsulitis v1
Protocol for PRP Therapy with Physiotherapy for Shoulder Adhesive Capsulitis v1
Background and Purpose: Adhesive capsulitis, or frozenshoulder, leads to pain and reduced mobility due to joint inflammation andfibrosis. While physiotherapy is the standard treatm...
Variability in Platelet-Rich Plasma Preparations Used in Regenerative Medicine: A Systematic Review.
Variability in Platelet-Rich Plasma Preparations Used in Regenerative Medicine: A Systematic Review.
Abstract
Background
Platelet-rich plasma (PRP) and its derivatives are used in several aesthetic, dental, and musculoskeletal procedures. Their efficacy is primarily due t...
PREPARATION AND IN VITRO WOUND HEALING EFFECTS OF ANIMAL-BASED PLATELET-RICH PLASMA LYSATE
PREPARATION AND IN VITRO WOUND HEALING EFFECTS OF ANIMAL-BASED PLATELET-RICH PLASMA LYSATE
Wound healing is a vital field of study in both human and veterinary medicine, particularly in the treatment of chronic wounds. Platelet-rich plasma, known for its potential to enh...
Efficacy of autologous platelet - rich plasma (PRP) in chronic wound treatment
Efficacy of autologous platelet - rich plasma (PRP) in chronic wound treatment
Abstract
Introduction: Chronic woundsare a global economic burden that have increased the morbidity and mortalityin patients. Chronic wounds present for an extended period of time ...
Comparative Efficacy of Intra-Articular PRP vs. Placebo Injections for Pain Management in Patients with Osteoarthritis of the Lower Limbs: A Systematic Review and Meta-Analysis
Comparative Efficacy of Intra-Articular PRP vs. Placebo Injections for Pain Management in Patients with Osteoarthritis of the Lower Limbs: A Systematic Review and Meta-Analysis
Background: Osteoarthritis (OA) is a prevalent degenerative joint disease that causes pain, disability, and a reduced quality of life. Traditional management strategies often provi...
Use of platelet-rich plasma in regenerative medicine: technical tools for correct quality control
Use of platelet-rich plasma in regenerative medicine: technical tools for correct quality control
Background/aims
Platelet-rich plasma (PRP) injections are used in sports medicine and have been the subject of increased clinical interest. However, there have be...

